Transglutaminases
-
Subject Areas on Research
- Advances in enzymology and related areas of molecular biology. Preface.
- Barnacle cement: a polymerization model based on evolutionary concepts.
- Celiac disease is not more prevalent in patients undergoing in vitro fertilization and does not affect reproductive outcomes with or without treatment: a large prospective cohort study.
- Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
- Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha.
- Decreased S -Nitrosylation of Tissue Transglutaminase Contributes to Age-Related Increases in Vascular Stiffness
- Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity.
- Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats.
- Endothelial cell-surface tissue transglutaminase inhibits neutrophil adhesion by binding and releasing nitric oxide.
- Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
- Glyceraldehyde 3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts.
- Human mononuclear phagocyte transglutaminase activity cross-links fibrin.
- Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.
- Leukocytoclastic vasculitis as the presenting feature of dermatitis herpetiformis.
- Management of dermatitis herpetiformis.
- Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis.
- Novel MRI and fluorescent probes responsive to the Factor XIII transglutaminase activity.
- PRDX6 attenuates oxidative stress- and TGFbeta-induced abnormalities of human trabecular meshwork cells.
- Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.
- Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases?
- Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
- Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population.
- SU5416 delays wound healing through inhibition of TGF-beta 1 activation.
- Seropositivity to celiac antigens in asymptomatic children with type 1 diabetes mellitus: association with weight, height, and bone mineralization.
- Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair.
- Tissue transglutaminase expression in human breast cancer.
- Tissue transglutaminase is expressed as a host response to tumor invasion and inhibits tumor growth.
- Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis.
- Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
- Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA.
- Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
- Transglutaminase 2 protects against ischemic stroke.
- Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.
- Visualization of purified fibronectin-transglutaminase complexes.
-
Keywords of People
- Erickson, Harold Paul, James B. Duke Distinguished Professor Emeritus, Cell Biology